Seismic Shifts in Heart Failure Management: How Sodium-Glucose Cotransporter-2 Inhibitors Are Changing How We Treat Our Patients

International expert faculty discuss how sodium-glucose cotransporter-2 (SGLT2) inhibitors have changed the management of patients with heart failure (HF). Credit available for this activity expires: [06/24/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976002?src=mkm_podcast_addon_976002